Timing of surgery following preoperative therapy in rectal cancer: The need for a prospective randomized trial?

Diseases of the Colon and Rectum

Volumn 54, Issue 10, 2011, Pages 1251-1259

  Evans, Jessica ^a,b   Tait, Diana ^a   Swift, Ian ^b   Pennert, Kjell ^a   Tekkis, Paris ^a   Wotherspoon, Andrew ^a   Chau, Ian ^a   Cunningham, David ^a   Brown, Gina ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chemoradiotherapy; Rectal cancer; Timing of surgery; Tumor downstaging

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIMARY TUMOR; RECTUM CANCER; RETROSPECTIVE STUDY; STANDARDIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052743030     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e3182281f4b     Document Type: Article

References (23)

1. Mawdsley S, Glynne-Jones R, Grainger J, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys. 2005; 63:745-752. (Pubitemid 41400061)
2. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
3. Bernstein TE, Endreseth BH, Romundstad P, Wibe A; Norwegian Colorectal Cancer Group. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009;96: 1348-1357.
4. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on down-staging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17: 2396-2402. (Pubitemid 29368238)
5. Johnston DF, Lawrence KM, Sizer BF, et al. Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy. Br J Radiol. 2009;82:332-336.
6. Kerr SF, Norton S, Glynne-Jones R. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg. 2008;95:1534-1540.
7. Habr-Gama A, Perez RO, Proscurshim I, et al. Interval between surgery and neo-adjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J. Radiat Oncol Biol. Phys. 2008;15:71:1181-1188.
8. Brown G, Daniels IR, Richardson C, Revell P, Peppercorn D, Bourne M. Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br J Radiol. 2005;78: 245-251. (Pubitemid 40467647)
9. MERCURY Study Group. Diagnostic accuracy of magnetic resonance imaging in predicting surgical resection margin status: prospective observational study. BMJ. 2006;33:779-784.
10. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxiliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol. 2006; 24:668-674. (Pubitemid 46630432)
11. Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg. 2010;97:580-587.
12. Kalady MF, de Campos-Lobato LF, Stocchi L, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009;250:582-589.
13. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835-844.
14. Beresford M, Glynne-Jones R, Richman P, et al. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol). 2005;17: 448-455. (Pubitemid 41136141)
15. Lindebjerg J, Spindler KL, Ploen J, Jakobsen A. The prognostic value of lymph node metastases and tumor regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis. 2009;11:264-269.
16. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum. 2002;45:895-903. (Pubitemid 34761469)
17. Kuo LJ, Liu MC, Jian JJ, et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol. 2007;14:2766-2772. (Pubitemid 47460637)
18. Lambregts MJ, Maas M, Riedl RG, et al. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer: a per lesion validation study. Eur Radiol. 2011;21:265-273.
19. Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys. 2008;72:99-107.
20. Sizer BF, Arulampalam T, Austin R, Lacey N, Menzies D, Motson R. MRI in predicting curative resection of rectal cancer: defining a "window of opportunity" for laparoscopic surgery. BMJ. 2006;14:333:808-809. (Pubitemid 44583369)
21. Brown G, Radcliffe AG, Newcourse RG, Dallimore NS, Bourne MW, Williams GT. Pre-operative assessment of prognostic factors in rectal cancer using high resolution magnetic resonance imaging. Br J Surg. 2003;90:355-364. (Pubitemid 36324117)
22. Glynne-Jones R, Mawdsley S, Harrison M. Cetuximab and chemoradiation for rectal cancer: is the water getting muddy? Acta Oncol. 2010;49:278-286.
23. Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 2010;28:1638-1644.